It has been shown that levels of MMPs 2 and 9 can affect the migratory and invasive capacity of tumor cells, inducing the release of VEGF, FGF-2, and TGFβ, which are proangiogenic factors. The gene discussed is VEGFA; the disease is neoplasm.